Department of Marine, Faculty of Fisheries and Marine, Universitas Airlangga, Surabaya 60115, Indonesia.
Department of Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan.
Molecules. 2019 Jul 12;24(14):2541. doi: 10.3390/molecules24142541.
Angiotensin I-converting enzyme (ACE) is a paramount therapeutic target to treat hypertension. ACE inhibitory peptides derived from food protein sources are regarded as safer alternatives to synthetic antihypertensive drugs for treating hypertension. Recently, marine organisms have started being pursued as sources of potential ACE inhibitory peptides. Marine organisms such as fish, shellfish, seaweed, microalgae, molluscs, crustaceans, and cephalopods are rich sources of bioactive compounds because of their high-value metabolites with specific activities and promising health benefits. This review aims to summarize the studies on peptides from different marine organisms and focus on the potential ability of these peptides to inhibit ACE activity.
血管紧张素转化酶(ACE)是治疗高血压的重要治疗靶点。来源于食物蛋白源的 ACE 抑制肽被认为是治疗高血压的合成抗高血压药物的更安全替代品。最近,海洋生物已开始被视为潜在 ACE 抑制肽的来源。鱼类、贝类、海藻、微藻、软体动物、甲壳类动物和头足类动物等海洋生物是具有特定活性和有前景的健康益处的高价值代谢物的丰富生物活性化合物来源。本综述旨在总结不同海洋生物来源的肽的研究,并重点关注这些肽抑制 ACE 活性的潜在能力。